APA

Biju P., Taveras A., Yu Y., Zheng J., Chao J., Rindgen D., Jakway J., Hipkin R. W., Fossetta J., Fan X., Fine J., Qiu H., Merritt J. R. & Baldwin J. J. (20080212). 3,4-Diamino-2,5-thiadiazole-1-oxides as potent CXCR2/CXCR1 antagonists. : Bioorganic & medicinal chemistry letters.

Chicago

Biju Purakkattle, Taveras Arthur, Yu Younong, Zheng Junying, Chao Jianhua, Rindgen Diane, Jakway James, Hipkin R William, Fossetta James, Fan Xuedong, Fine Jay, Qiu Hongchen, Merritt J Robert and Baldwin John J. 20080212. 3,4-Diamino-2,5-thiadiazole-1-oxides as potent CXCR2/CXCR1 antagonists. : Bioorganic & medicinal chemistry letters.

Harvard

Biju P., Taveras A., Yu Y., Zheng J., Chao J., Rindgen D., Jakway J., Hipkin R. W., Fossetta J., Fan X., Fine J., Qiu H., Merritt J. R. and Baldwin J. J. (20080212). 3,4-Diamino-2,5-thiadiazole-1-oxides as potent CXCR2/CXCR1 antagonists. : Bioorganic & medicinal chemistry letters.

MLA

Biju Purakkattle, Taveras Arthur, Yu Younong, Zheng Junying, Chao Jianhua, Rindgen Diane, Jakway James, Hipkin R William, Fossetta James, Fan Xuedong, Fine Jay, Qiu Hongchen, Merritt J Robert and Baldwin John J. 3,4-Diamino-2,5-thiadiazole-1-oxides as potent CXCR2/CXCR1 antagonists. : Bioorganic & medicinal chemistry letters. 20080212.